Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD

Neuropsychopharmacology

Volumn 35, Issue 3, 2010, Pages 656-664

  Franke, Barbara ^a,b   Vasquez, Alejandro Arias ^a,b   Johansson, Stefan ^c,d   Hoogman, Martine ^b   Romanos, Jasmin ^e   Boreatti Hümmer, Andrea ^e   Heine, Monika ^e   Jacob, Christian P ^e   Lesch, Klaus Peter ^e   Casas, Miguel ^f,g   Ribasés, Marta ^f   Bosch, Rosa ^f   Sánchez Mora, Cristina ^f   Gómez Barros, Nria ^f   Fernndez Castillo, Noèlia ^h   Bayés, Mònica ^i,j,k   Halmøy, Anne ^c   Halleland, Helene ^c   Landaas, Elisabeth T ^c,d   Fasmer, Ole B ^c,d   Knappskog, Per M ^c,d   Heister, Angelien J G A M ^a   Kiemeney, Lambertus A ^a   Kooij, J J Sandra ^l   Boonstra, A Marije ^l   Kan, Cees C ^b   Asherson, Philip ^m   Faraone, Stephen V ⁿ   Buitelaar, Jan K ^b   Haavik, Jan ^c,d   Cormand, Bru ^h,o   Ramos Quiroga, Josep Antoni ^f,g   Reif, Andreas ^e   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^j INSTITUTO DE SALUD CARLOS III   (Spain)

^k Centro Nacional de Genotipado CeGen   (Spain)

^l Program Adult ADHD   (Netherlands)

^m KING'S COLLEGE LONDON   (United Kingdom)

ⁿ SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^o CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

more..

Author keywords

Dopamine; Neurogenetics; Psychiatry and behavioral sciences; Transporters

Indexed keywords

ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; DAT1 GENE; GENE; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MENTAL DISEASE; PRIORITY JOURNAL; RISK FACTOR; SLC6A3 GENE; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HAPLOTYPES; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; MINISATELLITE REPEATS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 75749145001     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.170     Document Type: Article

References (49)

1. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP et al (2007). Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 164: 674-677.
2. Barkley RA, Fischer M, Smallish L, Fletcher K (2006a). Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45: 192-202.
3. Barkley RA, Smith KM, Fischer M, Navia B (2006b). An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuro-psychiatr Genet 141: 487-498.
4. Bernfort L, Nordfeldt S, Persson J (2008). ADHD from a socio-economic perspective. Acta Paediatr 97: 239-245.
5. Bertolino A, Di GA, Blasi G, Sambataro F, Caforio G, Sinibaldi L et al (2008). Epistasis between dopamine regulating genes identifies a nonlinear response of the human hippocampus during memory tasks. Biol Psychiatry 64: 226-234.
6. Biederman J, Mick E, Faraone SV (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 157: 816-818.
7. Brookes KJ, Mill J, Guindalini C, Curran S, Xu X, Knight J et al (2006). A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry 63: 74-81.
8. Brookes KJ, Neale BM, Sugden K, Khan N, Asherson P, D'Souza UM (2007). Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in postmortem midbrain tissue. Am J Med Genet B Neuropsychiatr Genet 144B: 1070-1078.
9. Brookes KJ, Xu X, Anney R, Franke B, Zhou K, Chen W et al (2008). Association of ADHD with genetic variants in the 5-region of the dopamine transporter gene: evidence for allelic heterogeneity. Am J Med Genet B Neuropsychiatr Genet 147B: 1519-1523.
10. Bruggemann D, Sobanski E, Alm B, Schubert T, Schmalzried H, Philipsen A et al (2007). No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3UTR of the DAT1 gene and adult attention deficit hyperactivity disorder. Psychiatr Genet 17: 121.
11. Cook Jr EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al (1995). Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56: 993-998.
12. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
13. Diamond A (2007). Consequences of variations in genes that affect dopamine in prefrontal cortex. Cereb Cortex 17(Suppl 1): i161-i170.
14. Faraone SV (2002). Report from the third international meeting of the Attention-Deficit Hyperactivity Disorder Molecular Genetics Network. Am J Med Genet 114: 272-276.
15. Faraone SV (2003). Report from the 4th international meeting of the attention deficit hyperactivity disorder molecular genetics network. Am J Med Genet B Neuropsychiatr Genet 121: 55-59.
16. Faraone SV (2004). Genetics of adult attention-deficit/hyperactiv-ity disorder. Psychiatr Clin North Am 27: 303-321.
17. Faraone SV, Biederman J, Mick E (2006). The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36: 159-165. (Pubitemid 43126140)
18. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E et al (2000). Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48: 9-20.
19. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA et al (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 1313-1323.
20. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J (2004). Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychophar-macol 24: 24-29.
21. Fleiss J (1981). Statistical Methods for Rates and Proportions. In. Wiley: New York.
22. Franke B, Hoogman M, Arias VA, Heister JG, Savelkoul PJ, Naber M et al (2008). Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD. Am J Med Genet B Neuropsychiatr Genet 147B: 1576-1579.
23. Goodman DW (2007). The consequences of attention-deficit/hyperactivity disorder in adults. J Psychiatr Pract 13: 318-327.
24. Guindalini C, Howard M, Haddley K, Laranjeira R, Collier D, Ammar N, et al (2006). A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci USA 103: 4552-5455
25. Guo G, Roettger ME, Shih JC (2007). Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Hum Genet 121: 125-136.
26. Halleland H, Lundervold AJ, Halmoy A, Haavik J, Johansson S (2008). Association between Catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in Adults. Am J Med Genet B Neuropsychiatr Genet 150B: 403-410.
27. Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P et al (2005a). The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med 47: 565-572.
28. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O et al (2006). The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163: 716-723.
29. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV et al (2005b). Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 57: 1442-1451.
30. Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP (2005). Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med 35: 817-827.
31. Lasky-Su J, Neale BM, Franke B, Anney RJ, Zhou K, Maller JB et al (2008). Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 147B: 1345-1354.
32. Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
33. Li D, Sham PC, Owen MJ, He L (2006). Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15: 2276-2284.
34. Madras BK, Miller GM, Fischman AJ (2005). The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 1397-1409.
35. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM (2002). Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 12: 207-215.
36. Mantel N, Haenzsel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
37. Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemela A, Trott GE et al (2008). A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylpheni-date in adults with attention-deficit/ hyperactivity disorder. Biol Psychiatry 63: 981-989.
38. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164: 942-948.
39. Raymond M, Rousset F (1995). GENEPOP (Version 1.2): population genetics software for exact tests and ecumenicism. J Heredity 86: 248-249.
40. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002). Score tests for association between traits and haplo-types when linkage phase is ambiguous. Am J Hum Genet 70: 425-434.
41. Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA et al (2005). In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 57: 1293-1300.
42. Staller J, Faraone SV (2006). Attention-deficit hyperactivity disorder in girls: epidemiology and management. CNS Drugs 20: 107-123.
43. The Cochrane Collaboration (2008). Review Manager (RevMan). In. The Nordic Cochrane Centre: Copenhagen.
44. Todd RD, Huang H, Smalley SL, Nelson SF, Willcutt EG, Pennington BF et al (2005). Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. J Child Psychol Psychiatry 46: 1067-1073.
45. Whitehead A (2002). Dealing with Heterogeneity. In. Whiley: Chicester. pp 151-174.
46. Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, Leuenberger B et al (2007). Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci USA 104: 8125-8130.
47. Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY (2007). A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144: 541-550.
48. Zhou K, Chen W, Buitelaar J, Banaschewski T, Oades RD, Franke B et al (2008). Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am J Med Genet B Neuropsychiatr Genet 147B: 1481-1487.
49. Zintzaras E, Hadjigeorgiou GM (2004). Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 49: 474-481.